Position in EDIT
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$198,913
+$106,986 QoQ
Shares Held
80,532
+79.6% QoQ
Ownership
0.082%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 99.76655242636467.ToString("F0")%
Shared 0.ToString("F0")%
None 0.2334475736353251.ToString("F0")%
Common Shares in EDIT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026STIFEL FINANCIAL CORP holds $433,142,280 across 103 Biotechnology names. EDIT ranks #84 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BHVN |
Biohaven Ltd.
|
9,940,885 | $84,099,887 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
161,052 | $71,916,158 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
48,907 | $37,787,502 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
139,514 | $26,375,120 | |
| 5 | OMER |
Omeros Corp
|
1,831,585 | $19,341,536 | |
| 6 | MANE |
Veradermics, Inc
|
294,117 | $18,573,488 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
49,954 | $16,528,277 | |
| 8 | IONS |
Ionis Pharmaceuticals Inc
|
196,703 | $14,770,427 |
All Filings in EDIT
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $198,913 | 80,532 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $91,927 | 44,843 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $2,013,588 | 580,285 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $1,221,593 | 555,270 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $411,552 | 354,787 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $428,190 | 337,158 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $2,130,827 | 624,876 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $2,116,536 | 453,220 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $1,734,076 | 233,703 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $1,545,969 | 152,613 | Shares | Defined | 2024-02-12 | |
| 2023-09-30 | $1,185,264 | 151,957 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $1,219,908 | 148,227 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $1,031,805 | 142,318 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $535,065 | 60,323 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $1,139,384 | 93,087 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,069,218 | 90,382 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $1,214,958 | 63,878 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $339,309 | 12,780 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $635,014 | 15,458 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $4,448,675 | 78,543 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $2,899,554 | 69,037 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $895,164 | 12,768 | Shares | Defined | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||